This site is intended for Healthcare Professionals only

Medicines

linctus-1280x720

Codeine linctus to be reclassified as POM because of risk of abuse

Codeine linctus is to be reclassified to a prescription-only medicine due to the risk of abuse, dependency and overdose, the MHRA has announced.

20 Feb 2024 , 1 Min Article

gene-1280x720

Genetic biobank recruiting patients on DOACs in pilot study

By collecting genetic samples, the Yellow Card Biobank aims to determine whether a suspected side effect was caused by a specific genetic trait.

13 Feb 2024 , 1 Min Article

safety-alert-summary

New valproate safety materials released by MHRA

Updated regulatory measures are now in place to reduce the known harms from valproate.

09 Feb 2024 , 3 Min Article

uber-1280x720

Healthera teams up with Uber for express delivery of medicines

Digital healthcare platform Healthera and Uber Direct have announced a partnership to enable the express delivery of prescriptions and over-the-counter medicines

30 Jan 2024 , 1 Min Article

john-pignone-1280

Clawback must “provide funding certainty” in Northern Ireland, says Phoenix director

Phoenix Medical Supplies sales director John Pignone has written to the government to express his concerns.

29 Jan 2024 , 1 Min Article

ofloxacin-1280x720

New restrictions on prescribing of fluoroquinolones

Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate, the MHRA advises after safety review

23 Jan 2024 , 1 Min Article

valproate-1280x720

New study suggests risk of disorders in children fathered by men taking valproate

The MHRA advises that, as a precaution, male patients on valproate who are planning a family in the next year should talk to their healthcare professional

16 Jan 2024 , 1 Min Article

semaglutide-summary

New patient safety alert issued concerning GLP-1 shortages

Supplies of the diabetes drug class not expected to return to normal until the end of 2024 at the earliest.

05 Jan 2024 , 2 Min Article

Out of stock 1280.jpg

Three brands of isosorbide mononitrate are out of stock, warns DHSC

Nyzamac SR 40mg capsules, Zemon 40XL 40mg tablets and Isotard 40XL 40mg tablets are out of stock.

04 Jan 2024 , 1 Min Article

online-pharmacy-summary

Best practice guidelines launched for online prescribing

Voluntary best practice guidelines have been launched for online care providers.

11 Dec 2023 , 2 Min Article

belfast-summary

Belfast pharmacist facing charges related to supply of opioids

Pharmacist faces a dozen charges in upcoming magistrate hearing

06 Dec 2023 , 1 Min Article

vpag-1280x720

Government and pharma industry reach agreement on branded medicines pricing

New five year VPAG sets yearly cap on the total allowed sales value of branded medicines to the NHS, with annual allowed growth in sales doubling from 2 to 4 per cent by 2027.

21 Nov 2023 , 1 Min Article

meds-1280x720

Two in five adults still requesting GP appointments for minor conditions

PAGB survey shows only 60 per cent of people using pharmacies as first step in seeking advice or medicines for self-treatable conditions, down from 69 per cent in 2022.

14 Nov 2023 , 1 Min Article

approved-1280

Scottish Medicines Consortium approves six new treatments

Tafamadis was approved for treating amyloidosis cardiomyopathy, a potentially fatal and undiagnosed condition.

13 Nov 2023 , 1 Min Article

Weight loss 1280.jpg

Diabetes drug authorised for weight loss and weight management

Mounjaro, also known as tirzepatide, has been authorised by the MHRA for weight loss and weight management in people aged 18 and over.

10 Nov 2023 , 1 Min Article

handling-blister-packs-summary

Eight per cent leap in community prescribing costs

NHS in England spent £9.6 billion on primary care medicines in 2022-23

08 Nov 2023 , 1 Min Article

Change privacy settings